Potent and subtype-selective CCK-B/gastrin receptor antagonists: 2,4-dioxo-1,5-benzodiazepines with a plane of symmetry
- PMID: 9377103
- DOI: 10.1016/s0968-0896(97)00083-7
Potent and subtype-selective CCK-B/gastrin receptor antagonists: 2,4-dioxo-1,5-benzodiazepines with a plane of symmetry
Abstract
A series of CCK-B/gastrin receptor antagonists, 2,4-dioxo-1,5-benzodiazepine derivatives with a plane of symmetry, were designed, synthesized, and evaluated for antagonistic activity. Structure-activity relationship studies revealed that carbonylmethyl groups at both N-1 and N-5 positions and hydrophilic groups, such as the carboxyl group on the benzene ring attached to the ureido group at the C-3 position, brought about potent affinity and subtype selectivity for CCK-B/gastrin receptors. Several compounds showed excellent in vivo inhibition of gastric acid secretion induced by pentagastrin in anesthetized rats.
Similar articles
-
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.J Pharmacol Exp Ther. 1994 May;269(2):725-31. J Pharmacol Exp Ther. 1994. PMID: 7910212
-
Synthesis and pharmacological properties of ureidomethylcarbamoylphenylketone derivatives. A new potent and subtype-selective nonpeptide CCK-B/gastrin receptor antagonist, S-0509.Bioorg Med Chem. 1997 Aug;5(8):1695-714. doi: 10.1016/s0968-0896(97)00104-1. Bioorg Med Chem. 1997. PMID: 9313871
-
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonists.Bioorg Med Chem. 1994 Sep;2(9):987-98. doi: 10.1016/s0968-0896(00)82047-7. Bioorg Med Chem. 1994. PMID: 7712133
-
CCK receptor antagonists.Gen Pharmacol. 1998 Oct;31(4):519-24. doi: 10.1016/s0306-3623(98)00078-0. Gen Pharmacol. 1998. PMID: 9792209 Review.
-
A second generation of non-peptide cholecystokinin receptor antagonists and their possible therapeutic potential.Ann N Y Acad Sci. 1994 Mar 23;713:312-8. doi: 10.1111/j.1749-6632.1994.tb44079.x. Ann N Y Acad Sci. 1994. PMID: 8185173 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous